Daniel Ansari
61 – 80 of 120
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
The challenges of centralization with HPB resectional surgery
(
- Contribution to journal › Letter
-
Mark
Postoperative pancreatic fistula-impact on outcome, hospital cost and effects of centralization
(
- Contribution to journal › Article
-
Mark
Characterization of histone-related chemical modifications in formalin-fixed paraffin-embedded and fresh-frozen human pancreatic cancer xenografts using LC-MS/MS
(
- Contribution to journal › Article
-
Mark
Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine
(
- Contribution to journal › Article
-
Mark
Impact of body constitution on complications following pancreaticoduodenectomy : A retrospective cohort study
(
- Contribution to journal › Article
-
Mark
Development and In Vitro Characterization of a Gemcitabine-loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Pancreatic cancer stroma : controversies and current insights
(
- Contribution to journal › Scientific review
-
Mark
Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
-
Mark
Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Intraductal papillary mucinous neoplasm of the pancreas–epidemiology, risk factors, diagnosis, and management
(
- Contribution to journal › Scientific review
-
Mark
Pancreatic ductal adenocarcinoma : Is a cure possible?
(
- Contribution to journal › Scientific review
-
Mark
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
- 2016
-
Mark
Immune checkpoint therapy for pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Pancreatic cancer : Yesterday, today and tomorrow
(
- Contribution to journal › Article
-
Mark
Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas
(
- Contribution to journal › Article
-
Mark
Pattern of tumour growth of the primary colon cancer predicts long-term outcome after resection of liver metastases
(
- Contribution to journal › Article
-
Mark
Paradoxical role of hmgb1 in pancreatic cancer : Tumor suppressor or tumor promoter?
(
- Contribution to journal › Scientific review
-
Mark
Safety of pancreatic resection in the elderly : a retrospective analysis of 556 patients
(
- Contribution to journal › Article
-
Mark
Comprehensive analysis of histone related modifications of formaldehyde fixed paraffin embedded and fresh frozen pancreatic tumor xenografts using LC-MS/MS
(
- Contribution to journal › Article